- Report
- July 2025
- 405 Pages
Global
From €6200EUR$6,995USD£5,390GBP
- Report
- July 2025
- 281 Pages
Global
From €6200EUR$6,995USD£5,390GBP
- Report
- August 2024
- 136 Pages
Global
From €2658EUR$2,999USD£2,311GBP
- Report
- February 2025
- 200 Pages
Global
From €3980EUR$4,490USD£3,460GBP
- Report
- January 2025
- 175 Pages
Global
From €3980EUR$4,490USD£3,460GBP
- Report
- July 2025
- 179 Pages
Global
From €5185EUR$5,850USD£4,508GBP
- Report
- March 2025
- 75 Pages
Global
From €3500EUR$4,230USD£3,149GBP
- Report
- May 2024
- 186 Pages
Global
From €3390EUR$3,825USD£2,948GBP
€3989EUR$4,500USD£3,468GBP
- Report
- October 2022
- 250 Pages
Global
From €3191EUR$3,600USD£2,774GBP
- Report
- September 2022
- 271 Pages
Global
From €3191EUR$3,600USD£2,774GBP
- Book
- April 2019
- 324 Pages
- Book
- December 2011
- 492 Pages
- Book
- August 2011
- 466 Pages
- Book
- April 2025
- 528 Pages
- Book
- June 2010
- 471 Pages

The Free Radical market is a subset of the biotechnology industry that focuses on the development of new technologies and products that can be used to combat oxidative stress. This includes the development of antioxidants, anti-inflammatory agents, and other compounds that can help protect cells from damage caused by free radicals. Free radicals are molecules that are produced naturally in the body, but can also be generated by environmental factors such as pollution, radiation, and smoking. These molecules can cause damage to cells and tissues, leading to a variety of diseases and conditions.
The Free Radical market is a rapidly growing sector of the biotechnology industry, with many companies developing new products and technologies to combat oxidative stress. Companies in this market include Amgen, Celgene, Gilead Sciences, and Regeneron Pharmaceuticals, among others. These companies are focused on developing new treatments and therapies to help protect cells from damage caused by free radicals. Show Less Read more